Credit Suisse’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-39,291
| Closed | -$12.4M | – | 3049 |
|
|
2023
Q4 | $12.4M | Buy |
39,291
+8,460
| +27% | +$2.68M | 0.01% | 825 |
|
|
2023
Q3 | $5.21M | Sell |
30,831
-836
| -3% | -$141K | 0.01% | 1238 |
|
|
2023
Q2 | $6.87M | Buy |
31,667
+6,997
| +28% | +$1.52M | 0.01% | 1121 |
|
|
2023
Q1 | $4.48M | Buy |
24,670
+1,690
| +7% | +$307K | ﹤0.01% | 1381 |
|
|
2022
Q4 | $4.52M | Sell |
22,980
-201
| -0.9% | -$39.5K | ﹤0.01% | 1360 |
|
|
2022
Q3 | $5.21M | Buy |
23,181
+4,959
| +27% | +$1.12M | 0.01% | 1215 |
|
|
2022
Q2 | $2.31M | Sell |
18,222
-1,169
| -6% | -$148K | ﹤0.01% | 1798 |
|
|
2022
Q1 | $2.46M | Buy |
19,391
+3,202
| +20% | +$406K | ﹤0.01% | 1933 |
|
|
2021
Q4 | $2.12M | Buy |
16,189
+1,066
| +7% | +$140K | ﹤0.01% | 2115 |
|
|
2021
Q3 | $1.85M | Buy |
15,123
+3,467
| +30% | +$424K | ﹤0.01% | 2194 |
|
|
2021
Q2 | $1.33M | Sell |
11,656
-4,373
| -27% | -$499K | ﹤0.01% | 2440 |
|
|
2021
Q1 | $1.93M | Sell |
16,029
-6,507
| -29% | -$782K | ﹤0.01% | 2173 |
|
|
2020
Q4 | $2.29M | Sell |
22,536
-4,010
| -15% | -$407K | ﹤0.01% | 2039 |
|
|
2020
Q3 | $2.05M | Sell |
26,546
-5,069
| -16% | -$392K | ﹤0.01% | 1800 |
|
|
2020
Q2 | $3.52M | Buy |
+31,615
| New | +$3.52M | ﹤0.01% | 1491 |
|